174 related articles for article (PubMed ID: 20465392)
1. Lipid rafts and clusters of apoptotic signaling molecule-enriched rafts in cancer therapy.
Mollinedo F; Gajate C
Future Oncol; 2010 May; 6(5):811-21. PubMed ID: 20465392
[TBL] [Abstract][Full Text] [Related]
2. Lipid rafts as major platforms for signaling regulation in cancer.
Mollinedo F; Gajate C
Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
[TBL] [Abstract][Full Text] [Related]
3. Lipid rafts and Fas/CD95 signaling in cancer chemotherapy.
Gajate C; Mollinedo F
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):274-83. PubMed ID: 21762074
[TBL] [Abstract][Full Text] [Related]
4. Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy.
Mollinedo F; Gajate C
Drug Resist Updat; 2006; 9(1-2):51-73. PubMed ID: 16687251
[TBL] [Abstract][Full Text] [Related]
5. Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas-enriched rafts in selective tumor cell apoptosis.
Gajate C; Del Canto-Jañez E; Acuña AU; Amat-Guerri F; Geijo E; Santos-Beneit AM; Veldman RJ; Mollinedo F
J Exp Med; 2004 Aug; 200(3):353-65. PubMed ID: 15289504
[TBL] [Abstract][Full Text] [Related]
6. Lipid raft connection between extrinsic and intrinsic apoptotic pathways.
Gajate C; Gonzalez-Camacho F; Mollinedo F
Biochem Biophys Res Commun; 2009 Mar; 380(4):780-4. PubMed ID: 19338752
[TBL] [Abstract][Full Text] [Related]
7. Clusters of apoptotic signaling molecule-enriched rafts, CASMERs: membrane platforms for protein assembly in Fas/CD95 signaling and targets in cancer therapy.
Mollinedo F; Gajate C
Biochem Soc Trans; 2022 Jun; 50(3):1105-1118. PubMed ID: 35587168
[TBL] [Abstract][Full Text] [Related]
8. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis.
Lincoln JE; Boling M; Parikh AN; Yeh Y; Gilchrist DG; Morse LS
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2172-8. PubMed ID: 16639029
[TBL] [Abstract][Full Text] [Related]
9. Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy.
Nieto-Miguel T; Gajate C; González-Camacho F; Mollinedo F
Oncogene; 2008 Mar; 27(12):1779-87. PubMed ID: 17891170
[TBL] [Abstract][Full Text] [Related]
10. Importance of lipid microdomains, rafts, in absorption, delivery, and biological effects of resveratrol.
Delmas D; Aires V; Colin DJ; Limagne E; Scagliarini A; Cotte AK; Ghiringhelli F
Ann N Y Acad Sci; 2013 Jul; 1290():90-7. PubMed ID: 23855470
[TBL] [Abstract][Full Text] [Related]
11. Lipid rafts and raft-mediated supramolecular entities in the regulation of CD95 death receptor apoptotic signaling.
Gajate C; Mollinedo F
Apoptosis; 2015 May; 20(5):584-606. PubMed ID: 25702154
[TBL] [Abstract][Full Text] [Related]
12. Beyond the "Lock and Key" Paradigm: Targeting Lipid Rafts to Induce the Selective Apoptosis of Cancer Cells.
Alves ACS; Dias RA; Kagami LP; das Neves GM; Torres FC; Eifler-Lima VL; Carvalho I; de Miranda Silva C; Kawano DF
Curr Med Chem; 2018; 25(18):2082-2104. PubMed ID: 29332565
[TBL] [Abstract][Full Text] [Related]
13. Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.
Mollinedo F; Gajate C
J Lipid Res; 2020 May; 61(5):611-635. PubMed ID: 33715811
[TBL] [Abstract][Full Text] [Related]
14. Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.
Remacle-Bonnet M; Garrouste F; Baillat G; Andre F; Marvaldi J; Pommier G
Am J Pathol; 2005 Sep; 167(3):761-73. PubMed ID: 16127155
[TBL] [Abstract][Full Text] [Related]
15. Lipid rafts, death receptors and CASMERs: new insights for cancer therapy.
Mollinedo F; Gajate C
Future Oncol; 2010 Apr; 6(4):491-4. PubMed ID: 20373862
[No Abstract] [Full Text] [Related]
16. Cetuximab enhances TRAIL-induced gastric cancer cell apoptosis by promoting DISC formation in lipid rafts.
Xu L; Hu X; Qu X; Hou K; Zheng H; Liu Y
Biochem Biophys Res Commun; 2013 Sep; 439(2):285-90. PubMed ID: 23973713
[TBL] [Abstract][Full Text] [Related]
17. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.
Gajate C; Mollinedo F
Anticancer Agents Med Chem; 2014 May; 14(4):509-27. PubMed ID: 24628241
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol and Sphingolipid Enriched Lipid Rafts as Therapeutic Targets in Cancer.
Codini M; Garcia-Gil M; Albi E
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450869
[TBL] [Abstract][Full Text] [Related]
19. Membrane rafts as a novel target in cancer therapy.
Hryniewicz-Jankowska A; Augoff K; Biernatowska A; Podkalicka J; Sikorski AF
Biochim Biophys Acta; 2014 Apr; 1845(2):155-65. PubMed ID: 24480320
[TBL] [Abstract][Full Text] [Related]
20. Distinct localization of lipid rafts and externalized phosphatidylserine at the surface of apoptotic cells.
Ishii H; Mori T; Shiratsuchi A; Nakai Y; Shimada Y; Ohno-Iwashita Y; Nakanishi Y
Biochem Biophys Res Commun; 2005 Feb; 327(1):94-9. PubMed ID: 15629434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
